Patents by Inventor Stefan Gottschalk
Stefan Gottschalk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20150183863Abstract: The present invention relates to a batch crystallization method for crystallizing an anti-hTNFalpha antibody which allows the production of said antibody on an industrial scale; antibody crystals as obtained according to said method; compositions containing said crystals as well as methods of use of said crystals and compositions.Type: ApplicationFiled: June 19, 2014Publication date: July 2, 2015Inventors: David W. Borhani, Wolfgang Fraunhofer, Hans-Juergen Krause, Anette Koenigsdorfer, Gerhard Winter, Stefan Gottschalk
-
Publication number: 20150166648Abstract: The present invention relates to a batch crystallization method for crystallizing anti-human TNFalpha (hTNFalpha) antibody and antibody fragments which allows the production of said antibody on an industrial scale; a method of controlling the size of antibody crystals, for example, crystals of anti-hTNFalpha antibody fragments, compositions containing said crystals as well as methods of use of said crystals and compositions.Type: ApplicationFiled: June 5, 2014Publication date: June 18, 2015Inventors: Wolfgang Fraunhofer, David W. Borhani, Gerhard Winter, Stefan Gottschalk
-
Patent number: 8940873Abstract: The invention relates to batch crystallization methods for crystallizing an anti-hIL-12 antibody that allows the production of the antibody on an industrial scale, antibody crystals obtained according to the methods, compositions containing the crystals, and methods of using the crystals and the compositions.Type: GrantFiled: February 7, 2013Date of Patent: January 27, 2015Assignee: AbbVie Inc.Inventors: David W. Borhani, Wolfgang Fraunhofer, Hans-Juergen Krause, Anette Koenigsdorfer, Gerhard Winter, Stefan Gottschalk
-
Patent number: 8772458Abstract: The present invention relates to a batch crystallization method for crystallizing an anti-hTNFalpha antibody which allows the production of said antibody on an industrial scale; antibody crystals as obtained according to said method; compositions containing said crystals as well as methods of use of said crystals and compositions.Type: GrantFiled: February 22, 2013Date of Patent: July 8, 2014Assignee: AbbVie Biotechnology LtdInventors: Anette Koenigsdorfer, Stefan Gottschalk, Hans-Juergen Krause, Gerhard Winter, David W. Borhani, Wolfgang Fraunhofer
-
Patent number: 8753839Abstract: The present invention relates to a batch crystallization method for crystallizing anti-human TNFalpha (hTNFalpha) antibody and antibody fragments which allows the production of said antibody on an industrial scale; a method of controlling the size of antibody crystals, for example, crystals of anti-hTNFalpha antibody fragments, compositions containing said crystals as well as methods of use of said crystals and compositions.Type: GrantFiled: August 8, 2008Date of Patent: June 17, 2014Assignee: Abbvie Inc.Inventors: Wolfgang Fraunhofer, David W. Borhani, Gerhard Winter, Stefan Gottschalk
-
Publication number: 20140017256Abstract: The invention relates to batch crystallization methods for crystallizing an anti-hIL-12 antibody that allows the production of the antibody on an industrial scale, antibody crystals obtained according to the methods, compositions containing the crystals, and methods of using the crystals and the compositions.Type: ApplicationFiled: February 7, 2013Publication date: January 16, 2014Applicant: ABBVIE INC.Inventors: David W. Borhani, Wolfgang Fraunhofer, Hans-Juergen Krause, Anette Koenigsdorfer, Gerhard Winter, Stefan Gottschalk
-
Patent number: 8436149Abstract: The present invention relates to a batch crystallization method for crystallizing an anti-hTNFalpha antibody which allows the production of said antibody on an industrial scale; antibody crystals as obtained according to said method; compositions containing said crystals as well as methods of use of said crystals and compositions.Type: GrantFiled: September 2, 2011Date of Patent: May 7, 2013Assignee: AbbVie Biotechnology LtdInventors: David W. Borhani, Wolfgang Fraunhofer, Hans-Juergen Krause, Anette Koenigsdorfer, Gerhard Winter, Stefan Gottschalk
-
Patent number: 8404819Abstract: The invention relates to batch crystallization methods for crystallizing an anti-hIL-12 antibody that allows the production of the antibody on an industrial scale, antibody crystals obtained according to the methods, compositions containing the crystals, and methods of using the crystals and the compositions.Type: GrantFiled: February 14, 2012Date of Patent: March 26, 2013Assignee: AbbVie Inc.Inventors: David W. Borhani, Wolfgang Fraunhofer, Hans-Juergen Krause, Anette Koenigsdorfer, Gerhard Winter, Stefan Gottschalk
-
Publication number: 20120251550Abstract: The present invention relates to a batch crystallization method for crystallizing an anti-hTNFalpha antibody which allows the production of said antibody on an industrial scale; antibody crystals as obtained according to said method; compositions containing said crystals as well as methods of use of said crystals and compositions.Type: ApplicationFiled: September 2, 2011Publication date: October 4, 2012Applicant: Abbott Biotechnology Ltd.Inventors: David W. Borhani, Wolfgang Fraunhofer, Hans-Juergen Krause, Anette Koenigsdorfer, Gerhard Winter, Stefan Gottschalk
-
Publication number: 20120177704Abstract: The invention relates to batch crystallization methods for crystallizing an anti-hIL-12 antibody that allows the production of the antibody on an industrial scale, antibody crystals obtained according to the methods, compositions containing the crystals, and methods of using the crystals and the compositions.Type: ApplicationFiled: February 14, 2012Publication date: July 12, 2012Inventors: David W. Borhani, Wolfgang Fraunhofer, Hans-Juergen Krause, Anette Koenigsdorfer, Gerhard Winter, Stefan Gottschalk
-
Patent number: 8168760Abstract: The invention relates to batch crystallization methods for crystallizing an anti-hIL-12 antibody that allows the production of the antibody on an industrial scale, antibody crystals obtained according to the methods, compositions containing the crystals, and methods of using the crystals and the compositions.Type: GrantFiled: March 27, 2008Date of Patent: May 1, 2012Assignee: Abbott LaboratoriesInventors: David W. Borhani, Wolfgang Fraunhofer, Hans-Juergen Krause, Anette Koenigsdorfer, Gerhard Winter, Stefan Gottschalk
-
Patent number: 8034906Abstract: The present invention relates to a batch crystallization method for crystallizing an anti-hTNFalpha antibody which allows the production of said antibody on an industrial scale; antibody crystals as obtained according to said method; compositions containing said crystals as well as methods of use of said crystals and compositions.Type: GrantFiled: October 25, 2007Date of Patent: October 11, 2011Assignee: Abbott Biotechnology Ltd.Inventors: David W. Borhani, Wolfgang Fraunhofer, Hans-Juergen Krause, Anette Koenigsdorfer, Gerhard Winter, Stefan Gottschalk
-
Publication number: 20100034823Abstract: The present invention relates to a batch crystallization method for crystallizing an anti-hTNFalpha antibody which allows the production of said antibody on an industrial scale; antibody crystals as obtained according to said method; compositions containing said crystals as well as methods of use of said crystals and compositions.Type: ApplicationFiled: October 25, 2007Publication date: February 11, 2010Inventors: David W. Borhani, Wolfgang Fraunhofer, Hans-Juergen Krause, Anette Koenigsdorfer, Gerhard Winter, Stefan Gottschalk
-
Publication number: 20090157763Abstract: A method and system for validating documentation. The method includes presenting a status mechanism operable to initiate a change in status of a portion of documentation, receiving a request to change the status of the portion of documentation, changing the status of the portion of documentation based on the request, and notifying an owner of the request to change the status of a portion of documentation. The method further includes presenting the portion of documentation to the owner and updating the status based on receiving a request to change the status of the portion of documentation. The system and method facilitate keeping documentation up to date.Type: ApplicationFiled: December 17, 2007Publication date: June 18, 2009Inventors: Stefan Gottschalk, Chris McIntosh, Olivier Giroux, Shaun Ho
-
Publication number: 20090148513Abstract: The present invention relates to a batch crystallization method for crystallizing anti-human TNFalpha (hTNFalpha) antibody and antibody fragments which allows the production of said antibody on an industrial scale; a method of controlling the size of antibody crystals, for example, crystals of anti-hTNFalpha antibody fragments, compositions containing said crystals as well as methods of use of said crystals and compositions.Type: ApplicationFiled: August 8, 2008Publication date: June 11, 2009Inventors: Wolfgang Fraunhofer, David W. Borhani, Gerhard Winter, Stefan Gottschalk
-
Publication number: 20080292642Abstract: The invention relates to batch crystallization methods for crystallizing an anti-hIL-12 antibody that allows the production of the antibody on an industrial scale, antibody crystals obtained according to the methods, compositions containing the crystals, and methods of using the crystals and the compositions.Type: ApplicationFiled: March 27, 2008Publication date: November 27, 2008Inventors: David W. Borhani, Wolfgang Fraunhofer, Hans-Juergen Krause, Anette Koenigsdorfer, Gerhard Winter, Stefan Gottschalk
-
Publication number: 20080028181Abstract: Circuits, methods, and apparatus that reduce or eliminate system memory accesses to retrieve address translation information. In one example, these accesses are reduced or eliminated by pre-populating a graphics TLB with entries that are used to translate virtual addresses used by a GPU to physical addresses used by a system memory. Translation information is maintained by locking or restricting entries in the graphics TLB that are needed for display access. This may be done by limiting access to certain locations in the graphics TLB, by storing flags or other identifying information in the graphics TLB, or by other appropriate methods. In another example, memory space is allocated by a system BIOS for a GPU, which stores a base address and address range. Virtual addresses in the address range are translated by adding them to the base address.Type: ApplicationFiled: March 21, 2007Publication date: January 31, 2008Applicant: NVIDIA CorporationInventors: Peter C. Tong, Sonny S. Yeoh, Kevin J. Kranzusch, Gary D. Lorensen, Kaymann L. Woo, Ashish Kishen Kaul, Colyn S. Case, Stefan A. Gottschalk, Dennis K. Ma